December 31, 2012
TB is a very serious disease worldwide. Almost one-third of the world's population, and one third of people with HIV, are infected with TB. A healthy immune system can usually prevent active disease. TB is a major cause of death for people with HIV worldwide, according to the World Health Organization.
The name tuberculosis comes from tubercles. These are small, hard lumps that form when the immune system builds a wall around the TB bacteria in the lungs. TB in the lungs is called pulmonary TB. The infection can spread from the lungs to the kidneys, spine and brain. This is called extrapulmonary TB. It only shows up in people who have already been infected with TB but who have not been treated. People with HIV who live in areas where TB is common might develop extrapulmonary TB.
Active TB in the lungs can cause coughing for more than 3 weeks, weight loss, constant fatigue, night sweats, and fevers, especially in the evening. These are like the symptoms caused by Pneumocystis pneumonia (PCP, see Fact Sheet 515). The symptoms can vary if TB is in other parts of the body. If people with HIV and TB have unexplained symptoms, they should rule out active TB disease.
TB is transmitted through the air, when someone with active TB coughs, sneezes or talks. TB particles can also be spread by speaking. The ultraviolet rays in sunlight can kill TB. Good ventilation reduces the risk of TB infection. However, people who live in close contact with people who have active TB become infected easily. This is especially true if you have advanced HIV disease. You can become infected with TB at any CD4 level.
The rate of TB for people with HIV in the United States is 40 times the rate for people who aren't HIV-infected. TB rates all over the world are increasing because of HIV disease.
TB can make HIV multiply faster, lower the CD4 cell count, and make HIV disease worse. This makes it important for people with HIV to prevent and treat TB.
If HIV or another disease has damaged your immune system, you might not show any reaction to the skin test, even if you're infected. This condition is called "anergy." If you have anergy, the most common way to test for TB is a sputum culture (see next paragraph).
A positive skin test usually doesn't mean you have active TB. Your health care provider will check x-rays of your lungs, ask you about other symptoms, examine samples of your sputum (fluid produced in the airways and lungs) and try to grow TB bacteria from those samples. They might also try to grow TB from samples taken from other parts of your body where TB can show up. This can take from two to four weeks depending on what method is used. It is difficult to diagnose active TB, especially in people with HIV, because it can look like pneumonia, other lung problems, or other infections. It can show up outside of the lungs. However, newer, faster tests are being developed.
If you have active TB disease, you will be treated with antibiotics. Because the TB bacteria can develop resistance to individual drugs, you will be given a combination of antibiotics. TB drugs must be taken for at least 6 months, but most cases of TB can be cured with existing antibiotics. If you don't keep taking the medications, the TB in your body might become resistant and the anti-TB drugs will stop working.
There are types of TB that are resistant to some antibiotics. These are called multi-drug resistant TB (MDR-TB) or extensively drug resistant TB (XDR-TB). These types of TB are much harder to treat. More medications have to be taken for a longer period of time. Cure rates are lower than for regular TB. Sirturo (bedaquiline) is the first new TB drug in over 40 years. The FDA approved it at the end of 2012. It works against TB with resistance to current drugs.
Also, many ARVs interact with rifampin or rifabutin, which are commonly used to fight TB. They can drop the levels of ARVs in your blood too low to control HIV. ARVs can raise the levels of these TB drugs high enough to cause serious side effects.
Rifampin should not be used with most protease inhibitors or non-nucleoside reverse transcriptase inhibitors. Rifabutin can be used in some cases, but drug doses might have to be changed. There are special guidelines if you take drugs to fight TB and HIV at the same time. They are available on the Internet at www.cdc.gov/tb/publications/factsheets/treatment/treatmentHIVpositive.htm.
Also, people with a CD4 cell count below 100 should take rifabutin at least 3 times a week. This reduces the risk of their TB becoming resistant to rifabutin.
For these reasons, TB should usually be cured first before ART is started. However, this may not be possible if CD4 cell counts are low.
There are effective treatments for TB infection, and for active TB disease. If you are exposed to TB, or have signs of TB, get tested and treated.
The treatments for TB take a long time, and can be difficult to take at the same time as ARVs, but they can cure TB. Some TB drugs interact with ARVs, so treatment has to be carefully planned if you have both HIV and TB. Be sure you understand how important it is to take TB medications for the complete length of time they are prescribed.